Table of Content

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Preclinical CRO Market, by Region

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing R&D activities by pharmaceutical and biopharmaceutical companies to develop new drugs & therapies
5.1.1.2. Rising trend of outsourcing drug development activities to CROs by pharmaceutical companies
5.1.1.3. Growing focus on the development of personalized medicines
5.1.2. Restraints
5.1.2.1. High cost and time-consuming constraints associated with preclinical CRO services
5.1.3. Opportunities
5.1.3.1. Growing advances in technologies to enable more efficient and cost-effective preclinical research
5.1.3.2. High potential for preclinical research for biologics, including monoclonal antibodies, vaccines, and cell therapies
5.1.4. Challenges
5.1.4.1. Stringent regulations and guidelines set by international regulatory authorities
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Presence of well-established pharmaceutical & biopharmaceutical companies and the rising introduction of advanced preclinical CRO platforms in the Americas
5.3.2. Rising government support for expanding research & development activities into developing new drugs and medical devices in the Asia-Pacific region
5.3.3. Potential government funding in drug development activities expands the preclinical CRO business in the EMEA region.
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Preclinical CRO Market, by Services
6.1. Introduction
6.2. Bioanalysis & DMPK Studies
6.3. Toxicology Testing

7. Preclinical CRO Market, by Application
7.1. Introduction
7.2. Cardiovascular Disease
7.3. Dermatology
7.4. Gastrointestinal
7.5. Genitourinary & Women’s Health
7.6. Hematology
7.7. Immunological Disorders
7.8. Infectious Diseases
7.9. Metabolic Disorders
7.10. Neurology
7.11. Oncology
7.12. Ophthalmology
7.13. Respiratory Disorders

8. Preclinical CRO Market, by End-User
8.1. Introduction
8.2. Biopharmaceutical Companies
8.3. Government & Academic Institutes
8.4. Medical Device Companies

9. Americas Preclinical CRO Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Preclinical CRO Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Preclinical CRO Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. AmplifyBio Expands Cell Therapy Characterization, Fills Gap in Preclinical Development
12.3.1.2. Clinchoice Continues Expansion with CRO Acquisition
12.3.1.3. CRO Avania Acquires MAXIS
12.3.1.4. Apax Acquires a Majority Stake in Porsolt to Support its Growth Strategy and Become a Global Leader in Preclinical Services
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Cryoport Announces Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
12.3.2.2. Crown Bioscience and ERS Genomics Announce Global CRISPR/Cas9 Licensing Agreement for Genome Editing Patents
12.3.2.3. Domain Therapeutics and Explicyte Enter Partnership Agreement in Immuno-Oncology
12.3.2.4. Hera BioLabs Announces Exclusive Global License With Charles River
12.3.2.5. IonsGate Preclinical Services and InSilicoTrials Form Partnership
12.3.3. New Product Launch & Enhancement
12.3.3.1. PsychoGenics Launches eCube, a New AI-Enabled Platform for Drug Discovery
12.3.4. Investment & Funding
12.3.4.1. CRO Company TriApex Completes Series C Financing Round Led by Legend Capital
12.3.4.2. ClinChoice Raises USD 150 Million in Series E Round
12.3.5. Award, Recognition, & Expansion
12.3.5.1. Proscia Announces Major Expansion in Preclinical R&D to Drive Faster Drug Safety Decisions
12.3.5.2. ??QPS opens an additional preclinical research facility in Taiwan
12.3.5.3. Celerion Expands Early Phase Clinical Pharmacology Units

13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. 10x Genomics, Inc.
13.1.2. AmplifyBio
13.1.3. Atuka Inc.
13.1.4. BenchSci
13.1.5. Bioserve Biotechnologies (India) PVT Ltd. by REPROCELL Inc.
13.1.6. Biotrofix, Inc.
13.1.7. Celerion
13.1.8. Charles River Laboratories International, Inc.
13.1.9. Crown Bioscience, Inc.
13.1.10. CTI Clinical Trial and Consulting, Inc.
13.1.11. Diag2Tec SAS
13.1.12. Eurofins Scientific SE
13.1.13. F. Hoffmann-La Roche Ltd.
13.1.14. Gubra
13.1.15. Hera Biolabs
13.1.16. ICON PLC
13.1.17. Immusmol SAS
13.1.18. ImQuest BioSciences
13.1.19. Inotiv, Inc.
13.1.20. Intertek Group PLC
13.1.21. Invivotek by Genesis Biotechnology Group, LLC
13.1.22. IQVIA Inc.
13.1.23. Jubilant Biosys Ltd. byJubilant Pharmova Limited Company
13.1.24. Laboratory Corporation of America Holding
13.1.25. MCI Group Holding SA
13.1.26. MD Biosciences
13.1.27. Medpace Holdings, Inc.
13.1.28. Novartis AG
13.1.29. Parexel International Corporation.
13.1.30. PharmaCircle LLC
13.1.31. Phenos GmbH
13.1.32. PPD by Thermo Fisher Scientific Inc.
13.1.33. PsychoGenics Inc.
13.1.34. QPS Holdings, LLC
13.1.35. Sanofi S.A.
13.1.36. SCiAN Services Inc.
13.1.37. SGS SA
13.1.38. Shanghai Medicilon Inc.
13.1.39. Syneos Health, Inc.
13.1.40. Transpharmation
13.1.41. Veristat, LLC
13.1.42. Vimta Labs Limited
13.1.43. WuXi AppTec Co., Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing



List of Figures

FIGURE 1. PRECLINICAL CRO MARKET RESEARCH PROCESS
FIGURE 2. PRECLINICAL CRO MARKET SIZE, 2022 VS 2030
FIGURE 3. PRECLINICAL CRO MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. PRECLINICAL CRO MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. PRECLINICAL CRO MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. PRECLINICAL CRO MARKET DYNAMICS
FIGURE 7. PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2022 VS 2030 (%)
FIGURE 8. PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 10. PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. PRECLINICAL CRO MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 12. PRECLINICAL CRO MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. PRECLINICAL CRO MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. PRECLINICAL CRO MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PRECLINICAL CRO MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 6. PRECLINICAL CRO MARKET SIZE, BY BIOANALYSIS & DMPK STUDIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. PRECLINICAL CRO MARKET SIZE, BY TOXICOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 9. PRECLINICAL CRO MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. PRECLINICAL CRO MARKET SIZE, BY DERMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. PRECLINICAL CRO MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. PRECLINICAL CRO MARKET SIZE, BY GENITOURINARY & WOMEN’S HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. PRECLINICAL CRO MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. PRECLINICAL CRO MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. PRECLINICAL CRO MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. PRECLINICAL CRO MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. PRECLINICAL CRO MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. PRECLINICAL CRO MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. PRECLINICAL CRO MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. PRECLINICAL CRO MARKET SIZE, BY RESPIRATORY DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. PRECLINICAL CRO MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. PRECLINICAL CRO MARKET SIZE, BY GOVERNMENT & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. PRECLINICAL CRO MARKET SIZE, BY MEDICAL DEVICE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. AMERICAS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 26. AMERICAS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 29. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 30. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. ARGENTINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. BRAZIL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 33. BRAZIL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34. BRAZIL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. CANADA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 36. CANADA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. CANADA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. MEXICO PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 39. MEXICO PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 40. MEXICO PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES PRECLINICAL CRO MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. CHINA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 53. CHINA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. CHINA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. INDIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 56. INDIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. INDIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. INDONESIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 59. INDONESIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. INDONESIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. JAPAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 62. JAPAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. JAPAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 65. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. MALAYSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 68. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. PHILIPPINES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 71. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. SINGAPORE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. SOUTH KOREA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. TAIWAN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 77. TAIWAN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 78. TAIWAN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. THAILAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 80. THAILAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 81. THAILAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. VIETNAM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 83. VIETNAM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. VIETNAM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 86. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 87. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. EUROPE, MIDDLE EAST & AFRICA PRECLINICAL CRO MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 89. DENMARK PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 90. DENMARK PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 91. DENMARK PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. EGYPT PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 93. EGYPT PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. EGYPT PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. FINLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 96. FINLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 97. FINLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. FRANCE PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. FRANCE PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. FRANCE PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. GERMANY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 102. GERMANY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 103. GERMANY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. ISRAEL PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 105. ISRAEL PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 106. ISRAEL PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. ITALY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 108. ITALY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. ITALY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 111. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 112. NETHERLANDS PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. NIGERIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. NIGERIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. NIGERIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. NORWAY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 117. NORWAY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 118. NORWAY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. POLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 120. POLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 121. POLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. QATAR PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 123. QATAR PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. QATAR PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. SAUDI ARABIA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 132. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 133. SOUTH AFRICA PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SPAIN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. SPAIN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. SPAIN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. SWEDEN PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 138. SWEDEN PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 139. SWEDEN PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 141. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 142. SWITZERLAND PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. TURKEY PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 144. TURKEY PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. TURKEY PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 149. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. UNITED KINGDOM PRECLINICAL CRO MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 152. PRECLINICAL CRO MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 153. PRECLINICAL CRO MARKET SHARE, BY KEY PLAYER, 2022
TABLE 154. PRECLINICAL CRO MARKET LICENSE & PRICING